First AD

Second AD

PRKAR1A-RET Fusion in Pancreatic Cancer: Unlocking New Therapeutic Frontiers

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

My Treatment Approach: Targeting Genetic Alterations in Tumors: Clinical Scenarios and Precision Oncology Approaches

OncLive Insights

Dr. Subbiah presents a pancreatic cancer case with PRKARA1A- RET fusion treated with selpercatinib in a clinical trial. 

PRKAR1A-RET Fusion in Pancreatic Cancer: Unlocking New Therapeutic Frontiers 

Overview of Tumor agnostic Treatment: Considerations for NGS Testing in Solid Tumors 

Targeting RET Fusion in Brain Tumor

BRAF V600E Mutant Ganglioglioma 

Challenges in Adopting Targeted Therapies for BRAF Alterations

Efficacy and Safety of Tumor Agnostic Therapies  

Impact and Positioning of Tumor Agnostic Approvals  

Future Outlook for RET Fusion-Targeted Therapies 